OC-0320 Comparing toxicities between Multicatheter Brachytherapy and Whole Breast External Beam Radiotherapy
نویسندگان
چکیده
منابع مشابه
Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy in Early-Stage Breast Cancer
There has not been a clear answer about the efficacy of intraoperative radiotherapy (IORT) for women with early-stage breast cancer.The aim of this meta-analysis was to summarize the available evidence comparing the efficacy and safety of IORT with those of whole-breast external beam radiotherapy (EBRT) for women with early-stage breast cancer.MEDLINE, EMBASE, the Web of Science, and the Cochra...
متن کاملCombining external beam radiotherapy with prostate brachytherapy: issues and rationale.
a he optimal treatment for clinically localized prostate cancer remains controversial. For paients with low-risk prostate cancer (Stage T1c2a, Gleason score less than 7, prostate-specific ntigen [PSA] of 10.0 ng/mL), monotherapy with adical prostatectomy, three-dimensional conforal radiotherapy (3D-CRT), intensity-modulated T, or prostate brachytherapy results in similar iochemical relapse-free...
متن کاملComparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation
BACKGROUND Brachytherapy as adjuvant treatment for early-stage breast cancer has become widely available and offers patients an expedited treatment schedule. Given this, many women are electing to undergo brachytherapy in lieu of standard fractionation radiotherapy. We compare outcomes between patients treated with accelerated partial breast irradiation (APBI) via multicatheter interstitial bra...
متن کاملBoost in radiotherapy: external beam sunset, brachytherapy sunrise
Radiobiological limitations for dose escalation in external radiotherapy are presented. Biological and clinical concept of brachytherapy boost to increase treatment efficacy is discussed, and different methods are compared. Oncentra Prostate 3D conformal real-time ultrasound-guided brachytherapy is presented as a solution for boost or sole therapy.
متن کاملSecond malignancies following conventional or combined 252Cf neutron brachytherapy with external beam radiotherapy for breast cancer
We retrospectively evaluated the risk of second malignancies among 832 patients with inner or central breast cancer treated with conventional external beam schedule (CRT group), or neutron brachytherapy using Californium-252 (²⁵²Cf) sources and hypofractionated external beam radiotherapy (HRTC group), between 1987 and 1996 at the Institute of Oncology, Vilnius University. Patients were observed...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2019
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(19)30740-6